Iron and Retinopathy of Prematurity (ROP)
NCT05133999
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Paris, France
View Trial DetailsNCT Number: NCT03347799
When a child was born too early, it is more likely to develop an alteration of its visual function than in the case of term birth. Significant visual disturbances are found in 3% of children born prematurely, but visual impairment can be very severe, up to the loss of vision in case of retinopathy of prematurity (ROP) in the most immature infants. The introduction of screening surveillance systems, such as WINROP software, might reduce the need for stressful eye examination in low risk neonates. This retrospective study aimed at validating the WINROP algorithm in a cohort of premature infants, born below 32 weeks of gestation, who had systematic eye examination for ROP screening over 4 year period.
Looking for future studies?
Notify Me24 week–40 week
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from birth up to 40 weeks post menstrual age
risk of retinopathy occurence
Time frame: from birth up to 40 weeks post menstrual age
standardized perinatal data collection
Central Hospital, Nancy, France
Other
WINROP Algorithm Validation for Retinopathy Screening in Premature Infants: a Retrospective Cohort Analysis Over 4 Years
Acronym: WINROP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05133999
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Paris, France
View Trial DetailsNCT00895869
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT03824782
Apnea, Arrhythmias, Cardiac
Toronto, Ontario, Canada
View Trial DetailsNCT01079715
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Florence, Italy
View Trial Details